Terms: = Endocrine gland cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Treatment
648 results:
1. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
2. Dihydrotanshinone I exhibits antitumor effects via β-catenin downregulation in papillary thyroid cancer cell lines.
Molteni E; Baldan F; Damante G; Allegri L
Sci Rep; 2024 Apr; 14(1):7853. PubMed ID: 38570592
[TBL] [Abstract] [Full Text] [Related]
3. Radiofrequency ablation for papillary thyroid microcarcinoma close to the thyroid capsule versus far from the thyroid capsule: a retrospective study.
Luo J; Hui T; Jin P; Sun Y; Chen Y; Lin Z; Huang P
Endokrynol Pol; 2024; 75(1):35-41. PubMed ID: 38497388
[TBL] [Abstract] [Full Text] [Related]
4. PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials.
Baradács I; Teutsch B; Váradi A; Bilá A; Vincze Á; Hegyi P; Fazekas T; Komoróczy B; Nyirády P; Ács N; Bánhidy F; Lintner B
J Ovarian Res; 2024 Feb; 17(1):53. PubMed ID: 38409030
[TBL] [Abstract] [Full Text] [Related]
5. Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25-a case report of rare entity.
Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
[TBL] [Abstract] [Full Text] [Related]
6. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial).
Vizzielli G; Giudice MT; Nardelli F; Costantini B; Salutari V; Inzani FS; Zannoni GF; Chiantera V; Di Giorgio A; Pacelli F; Fagotti A; Scambia G
Ann Surg Oncol; 2024 Feb; 31(2):1207-1216. PubMed ID: 38099993
[TBL] [Abstract] [Full Text] [Related]
7. The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report.
Findlay MC; Sabahi M; Azab M; Drexler R; Rotermund R; Ricklefs FL; Flitsch J; Smith TR; Kilgallon JL; Honegger J; Nasi-Kordhishti I; Gardner PA; Gersey ZC; Abdallah HM; Jane JA; Knappe UJ; Uksul N; Schroder HWS; Eördögh M; Losa M; Mortini P; Gerlach R; Antunes ACM; Couldwell WT; Budohoski KP; Rennert RC; Karsy M
Clin Neurol Neurosurg; 2024 Jan; 236():108079. PubMed ID: 38091700
[TBL] [Abstract] [Full Text] [Related]
8. A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers.
Tamura R; Kitani Y; Takahashi K; Yamaguchi M; Nishikawa N; Kawasaki T; Kikuchi A
J Obstet Gynaecol; 2023 Dec; 43(2):2283162. PubMed ID: 37983014
[TBL] [Abstract] [Full Text] [Related]
9. Endoscopic papillectomy for ampullary lesions of minor papilla.
Vu Trung K; Heise C; Abou-Ali E; Auriemma F; Karam E; van der Wiel SE; Bruno MJ; Caillol F; Giovannini M; Masaryk V; Will U; Anderloni A; Pérez-Cuadrado-Robles E; Dugic A; Meier B; Paik WH; Petrone MC; Wichmann D; Dinis-Ribeiro M; Gonçalves TC; Wedi E; Schmidt A; Gulla A; Hoffmeister A; Rosendahl J; Ratone JP; Saadeh R; Repici A; Deprez P; Sauvanet A; Souche FR; Fabre JM; Muehldorfer S; Caca K; Löhr M; Michl P; Krug S; Regner S; Gaujoux S; Hollenbach M
Gastrointest Endosc; 2024 Apr; 99(4):587-595.e1. PubMed ID: 37951279
[TBL] [Abstract] [Full Text] [Related]
10. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
[TBL] [Abstract] [Full Text] [Related]
11. Adamantinomatous craniopharyngioma: evolution in the management.
Massimi L; Palombi D; Musarra A; Bianchi F; Frassanito P; Tamburrini G; Di Rocco C
Childs Nerv Syst; 2023 Oct; 39(10):2613-2632. PubMed ID: 37728836
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of ultrasound-guided radiofrequency ablation of papillary thyroid microcarcinoma after one year.
Wang S; Yao N; Guo Z; Mao N; Wu H; Xu F; Li J
Asian J Surg; 2024 Jan; 47(1):350-353. PubMed ID: 37704471
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of ultrasound-guided radiofrequency, microwave and laser ablation for the treatment of T1N0M0 papillary thyroid carcinoma on a large scale: a systematic review and meta-analysis.
Gao X; Yang Y; Wang Y; Huang Y
Int J Hyperthermia; 2023 Dec; 40(1):2244713. PubMed ID: 37604507
[TBL] [Abstract] [Full Text] [Related]
14. High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic cancer.
Ischyropoulou M; Sabljo K; Schneider L; Niemeyer CM; Napp J; Feldmann C; Alves F
Adv Mater; 2023 Nov; 35(46):e2305151. PubMed ID: 37587542
[TBL] [Abstract] [Full Text] [Related]
15. Sound speed and attenuation of human pancreas and pancreatic tumors and their influence on focused ultrasound thermal and mechanical therapies.
Gray MD; Spiers L; Coussios CC
Med Phys; 2024 Feb; 51(2):809-825. PubMed ID: 37477551
[TBL] [Abstract] [Full Text] [Related]
16. The treatment of aggressive prolactinomas with everolimus.
Lin AL; Geer EB; Lala N; Page-Wilson G; Magge R; Young RJ; Tabar V
Pituitary; 2023 Aug; 26(4):474-481. PubMed ID: 37428396
[TBL] [Abstract] [Full Text] [Related]
17. Features of metabolism associated molecular patterns in pancreatic ductal adenocarcinoma.
Chen J; Wang Y; Jiang H
Cancer Gene Ther; 2023 Sep; 30(9):1296-1307. PubMed ID: 37414853
[TBL] [Abstract] [Full Text] [Related]
18. NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
Maithel SK; Keilson JM; Cao HST; Rupji M; Mahipal A; Lin BS; Javle MM; Cleary SP; Akce M; Switchenko JM; Rocha FG
Ann Surg Oncol; 2023 Oct; 30(11):6558-6566. PubMed ID: 37368098
[TBL] [Abstract] [Full Text] [Related]
19. The application of radiofrequency ablation in pancreatic cancer liver-only recurrence after radical pancreatectomy.
Wang C; Song L; Wang Z; Wang W
Med Oncol; 2023 Jun; 40(7):209. PubMed ID: 37347340
[TBL] [Abstract] [Full Text] [Related]
20. Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study.
Han ZY; Dou JP; Zheng L; Che Y; Yu MA; Wang SR; Wang H; Cong ZB; He JF; Qian TG; Hu QH; He GZ; Liu G; Yu SY; Guo JQ; Jiang TA; Feng RF; Li QY; Chen XJ; Zhu YL; Wei Y; Liu LH; Wang X; Qi LN; Liang P
Eur Radiol; 2023 Nov; 33(11):7942-7951. PubMed ID: 37294329
[TBL] [Abstract] [Full Text] [Related]
[Next]
